{"brief_title": "Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode", "brief_summary": "The purpose of this study is to evaluate flexible doses (5-30mg) of aripiprazole versus placebo in patients with bipolar depression.", "condition": ["Bipolar Disorder"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Aripiprazole", "Placebo"], "description": ["Tablets, Oral, 10mg (2 5mg tablets), Once daily, 8 weeks.", "Tablets, Oral, 0 mg, Once daily, 8 weeks."], "arm_group_label": ["A1", "A2"], "other_name": ["Abilify"], "criteria": "- ages 18-65 - Men and women, who have experienced a prior manic episode that required hospitalization, and now meet criteria for a major depressive episode.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "Bipolar 1 Disorder, depressed", "mesh_term": ["Disease", "Bipolar Disorder", "Aripiprazole"], "id": "NCT00080314"}